These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20518484)

  • 1. Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39.
    Minegishi S; Asada A; Miyauchi S; Fuchigami T; Saito T; Hisanaga S
    Biochemistry; 2010 Jul; 49(26):5482-93. PubMed ID: 20518484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes.
    Asada A; Yamamoto N; Gohda M; Saito T; Hayashi N; Hisanaga S
    J Neurochem; 2008 Aug; 106(3):1325-36. PubMed ID: 18507738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.
    Asada A; Saito T; Hisanaga S
    J Cell Sci; 2012 Jul; 125(Pt 14):3421-9. PubMed ID: 22467861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the different stability and activity between the Cdk5 complexes with p35 and p39 activators.
    Saito T; Yano M; Kawai Y; Asada A; Wada M; Doi H; Hisanaga SI
    J Biol Chem; 2013 Nov; 288(45):32433-32439. PubMed ID: 24085300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential targeting of p39-activated Cdk5 to Rac1-induced lamellipodia.
    Ito Y; Asada A; Kobayashi H; Takano T; Sharma G; Saito T; Ohta Y; Amano M; Kaibuchi K; Hisanaga S
    Mol Cell Neurosci; 2014 Jul; 61():34-45. PubMed ID: 24877974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid.
    Tsai SY; Pokrass MJ; Klauer NR; Nohara H; Su TP
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6742-7. PubMed ID: 25964330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29.
    Patzke H; Tsai LH
    J Biol Chem; 2002 Mar; 277(10):8054-60. PubMed ID: 11784720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdk5--p39 is a labile complex with the similar substrate specificity to Cdk5--p35.
    Yamada M; Saito T; Sato Y; Kawai Y; Sekigawa A; Hamazumi Y; Asada A; Wada M; Doi H; Hisanaga SI
    J Neurochem; 2007 Sep; 102(5):1477-1487. PubMed ID: 17394551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpastatin, an endogenous calpain-inhibitor protein, regulates the cleavage of the Cdk5 activator p35 to p25.
    Sato K; Minegishi S; Takano J; Plattner F; Saito T; Asada A; Kawahara H; Iwata N; Saido TC; Hisanaga S
    J Neurochem; 2011 May; 117(3):504-15. PubMed ID: 21338355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
    Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
    J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation.
    Saito T; Onuki R; Fujita Y; Kusakawa G; Ishiguro K; Bibb JA; Kishimoto T; Hisanaga S
    J Neurosci; 2003 Feb; 23(4):1189-97. PubMed ID: 12598607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent kinase 5 activators p35 and p39 facilitate formation of functional synapses.
    Johansson JU; Lilja L; Chen XL; Higashida H; Meister B; Noda M; Zhong ZG; Yokoyama S; Berggren PO; Bark C
    Brain Res Mol Brain Res; 2005 Aug; 138(2):215-27. PubMed ID: 15908038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner.
    Dhavan R; Greer PL; Morabito MA; Orlando LR; Tsai LH
    J Neurosci; 2002 Sep; 22(18):7879-91. PubMed ID: 12223541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair.
    Bankston AN; Li W; Zhang H; Ku L; Liu G; Papa F; Zhao L; Bibb JA; Cambi F; Tiwari-Woodruff SK; Feng Y
    J Biol Chem; 2013 Jun; 288(25):18047-57. PubMed ID: 23645679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
    Seyb KI; Ansar S; Li G; Bean J; Michaelis ML; Dobrowsky RT
    J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.
    Ko J; Humbert S; Bronson RT; Takahashi S; Kulkarni AB; Li E; Tsai LH
    J Neurosci; 2001 Sep; 21(17):6758-71. PubMed ID: 11517264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.
    Takasugi T; Minegishi S; Asada A; Saito T; Kawahara H; Hisanaga S
    J Biol Chem; 2016 Feb; 291(9):4649-57. PubMed ID: 26631721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Biochem Biophys Res Commun; 2002 Nov; 298(5):693-8. PubMed ID: 12419309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.